ESR1 and breast cancer: The findings support that cancer stem cell markers are considerably expressed in ER+ BC and have variable, yet significant, associations with each other and with key clinicopathologic prognostic indicators, such as Ki‐67, Progesterone receptor, and perinodal fat invasion.